GB0305579D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB0305579D0
GB0305579D0 GBGB0305579.5A GB0305579A GB0305579D0 GB 0305579 D0 GB0305579 D0 GB 0305579D0 GB 0305579 A GB0305579 A GB 0305579A GB 0305579 D0 GB0305579 D0 GB 0305579D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0305579.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DALLAS BURSTON Ltd
Original Assignee
DALLAS BURSTON Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DALLAS BURSTON Ltd filed Critical DALLAS BURSTON Ltd
Priority to GBGB0305579.5A priority Critical patent/GB0305579D0/en
Publication of GB0305579D0 publication Critical patent/GB0305579D0/en
Priority to GB0328023A priority patent/GB2399286A/en
Priority to KR1020057016853A priority patent/KR20050115276A/en
Priority to ZA200506248A priority patent/ZA200506248B/en
Priority to AU2004218876A priority patent/AU2004218876B2/en
Priority to PCT/GB2004/001037 priority patent/WO2004080382A2/en
Priority to JP2006500257A priority patent/JP2006519770A/en
Priority to MXPA05009602A priority patent/MXPA05009602A/en
Priority to CN2004800051154A priority patent/CN1784228B/en
Priority to NZ541781A priority patent/NZ541781A/en
Priority to CA002516338A priority patent/CA2516338A1/en
Priority to BRPI0408209-5A priority patent/BRPI0408209A/en
Priority to EP04719527A priority patent/EP1608372A2/en
Priority to NO20054172A priority patent/NO20054172L/en
Priority to US11/224,383 priority patent/US20060062812A1/en
Priority to HK05112165.9A priority patent/HK1084012A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
GBGB0305579.5A 2003-03-11 2003-03-11 Pharmaceutical compositions Ceased GB0305579D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB0305579.5A GB0305579D0 (en) 2003-03-11 2003-03-11 Pharmaceutical compositions
GB0328023A GB2399286A (en) 2003-03-11 2003-12-03 Sub-lingual fentanyl formulation
EP04719527A EP1608372A2 (en) 2003-03-11 2004-03-11 Compositions containing fentanyl
JP2006500257A JP2006519770A (en) 2003-03-11 2004-03-11 New composition
NZ541781A NZ541781A (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl
AU2004218876A AU2004218876B2 (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl
PCT/GB2004/001037 WO2004080382A2 (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl
KR1020057016853A KR20050115276A (en) 2003-03-11 2004-03-11 Novel compositions
MXPA05009602A MXPA05009602A (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl.
CN2004800051154A CN1784228B (en) 2003-03-11 2004-03-11 Novel compositions
ZA200506248A ZA200506248B (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl
CA002516338A CA2516338A1 (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl
BRPI0408209-5A BRPI0408209A (en) 2003-03-11 2004-03-11 new compositions
NO20054172A NO20054172L (en) 2003-03-11 2005-09-07 New mixtures
US11/224,383 US20060062812A1 (en) 2003-03-11 2005-09-12 Novel compositions
HK05112165.9A HK1084012A1 (en) 2003-03-11 2005-12-30 Compositions containing fentanyl

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0305579.5A GB0305579D0 (en) 2003-03-11 2003-03-11 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB0305579D0 true GB0305579D0 (en) 2003-04-16

Family

ID=9954572

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0305579.5A Ceased GB0305579D0 (en) 2003-03-11 2003-03-11 Pharmaceutical compositions
GB0328023A Withdrawn GB2399286A (en) 2003-03-11 2003-12-03 Sub-lingual fentanyl formulation

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0328023A Withdrawn GB2399286A (en) 2003-03-11 2003-12-03 Sub-lingual fentanyl formulation

Country Status (4)

Country Link
CN (1) CN1784228B (en)
GB (2) GB0305579D0 (en)
HK (1) HK1084012A1 (en)
ZA (1) ZA200506248B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101378735B (en) 2006-01-25 2013-04-03 英西斯治疗学股份有限公司 Sublingual fentanyl spray
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
EP2180844B1 (en) 2007-08-02 2018-02-21 Insys Development Company, Inc. Sublingual fentanyl spray

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0480054B1 (en) * 1990-03-30 1996-10-02 Morimoto, Yasunori Percutaneously absorbable composition of morphine hydrochloride
EP1307194B2 (en) * 2000-07-31 2011-04-27 Nycomed Danmark ApS Fentanyl composition for nasal administration
CN2474155Y (en) * 2000-12-12 2002-01-30 王玉文 Pen shaped atomizer with rotary jet tube

Also Published As

Publication number Publication date
CN1784228B (en) 2012-06-06
GB0328023D0 (en) 2004-01-07
ZA200506248B (en) 2006-10-25
HK1084012A1 (en) 2006-07-21
GB2399286A (en) 2004-09-15
CN1784228A (en) 2006-06-07

Similar Documents

Publication Publication Date Title
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
GB2389530B (en) Pharmaceutical compositions
EP1765283A4 (en) Pharmaceutical compositions
ZA200605080B (en) Pharmaceutical compositions
GB2391473B (en) Pharmaceutical compositions
HU0301154D0 (en) Pharmaceutical composition
GB0300531D0 (en) Pharmaceutical compositions
GB0300427D0 (en) Pharmaceutical composition
HK1084670A1 (en) Pharmaceutical compositions comprising cabbinochreme type compounds
EP1648411A4 (en) Pharmaceutical compositions
GB0307866D0 (en) Pharmaceutical composition
EP1805154A4 (en) Pharmaceutical compositions
EP1699458A4 (en) Pharmaceutical composition
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
HK1093896A1 (en) Medicinal composition
HU0302441D0 (en) Pharmaceutical compositions having antibiothic effect
GB0300885D0 (en) Pharmaceutical composition
EP1655029A4 (en) Medicinal compositions
GB0213481D0 (en) Pharmaceutical compositions
EP1600445A4 (en) Medicinal composition
GB0306933D0 (en) Pharmaceutical composition
EP1480649A4 (en) Stable pharmaceutical compositions
GB0305579D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)